Carolina Moresi Vieira

Ms. Carolina Moresi Vieira

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2025 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
Anna Luíza Soares de Oliveira RodriguesAnna Luíza Soares de Oliveira Rodrigues
Anna Luíza Soares de Oliveira Rodrigues
ISIsadora Fregonese Antunes Salomão
Isadora Fregonese Antunes Salomão
ISIsabela Fernandes Scabello
Isabela Fernandes Scabello
CVCarolina Moresi Vieira
Carolina Moresi Vieira
DCDeivyd Vieira Silva Cavalcante
Deivyd Vieira Silva Cavalcante
RCRafael Lucas Costa de Carvalho
Rafael Lucas Costa de Carvalho

18 November 2025 in COVID
Verified
Journal Article
Open access
PDF file
CCCláudia Patrícia Araujo Crainey
Cláudia Patrícia Araujo Crainey
CVCarolina Moresi Vieira
Carolina Moresi Vieira
KOKetlen Christine Ohse
Ketlen Christine Ohse
ASAlessandra S. Silva
Alessandra S. Silva
SCSofia Angiole Cavalcante
Sofia Angiole Cavalcante
PAPriscila Ferreira Aquino
Priscila Ferreira Aquino
This study investigated proteomic differences in nasopharyngeal swabs of SARS-CoV-2-infected patients from Manaus (Brazil) who were hospitalized during the devastating first wave of the COVID-19 pandemic, before the emergence of the deadly P1 SARS-CoV-2 strain. LC-MS/MS proteomic analysis compared 16 matched COVID-19 patient profiles: eight survivors and eight fatalities. A total of 1604 proteins were identified in fatality swabs, and 981 in the swabs of survivors. Our study provides new insights into the cellular mechanisms underlying first-wave COVID-19 deaths from Manaus and identifies hypoxia-related HYOU1, endothelial injury-associated S100A10, and some viral replication proteins (DDX1/17, XPO1) as potential biomarkers of fatal infections. The proteomic profiles of the swabs taken from patients that died collectively suggest that many of the first wave COVID-19 fatalities in Manaus suffered immune-system collapse. Survivor patient swabs showed elevated levels of immune defense proteins (FN1, C4BPA, IGKV1-5), indicating effective antiviral responses. Gene ontology analysis revealed dysregulated secretory pathways in fatalities and did not detect the defense-response pathways in fatality-group datasets that were observed in survivor protein datasets. Interestingly, the NOS2 protein, previously associated with first-wave fatalities, was found exclusively in our fatality swabs.